Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Bionxt Solutions Inc (BNXTF)

Bionxt Solutions Inc (BNXTF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
BioNxt Reports “Intention to Grant” Patent Notification from the European Patent Office for Its Oral Cladribine Sublingual Thin-Film as the Multiple Sclerosis Market Shifts Toward Patient-Friendly Therapies PressReach - Tue Nov 4, 12:17PM CST

VANCOUVER, BC / November 4, 2025 / BioNxt Solutions Inc. (“BioNxt” or the “Company”) (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to announce that its wholly owned German subsidiary, Vektor Pharma...

BNXT.CN : 0.6300 (+5.00%)
BNXTF : 0.4426 (+0.52%)
BioNxt Reports “Readiness to Grant” Patent Notification from the Eurasian Patent Organization PressReach - Thu Oct 30, 9:11AM CDT

VANCOUVER, BC / October 30, 2025 / BioNxt Solutions Inc. (“BioNxt” or the “Company”) (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is...

BNXT.CN : 0.6300 (+5.00%)
BNXTF : 0.4426 (+0.52%)
BioNxt Enters the Final Stretch Before Human Trials for Next-Generation MS Drug PR Newswire - Thu Oct 23, 4:29AM CDT

NEW YORK , Oct. 23, 2025 /PRNewswire/ -- BioNxt Solutions Inc. (CSE:BNXT) (OTCQB:BNXTF) (FSE:BXT), a bioscience company developing next-generation drug delivery technologies, has launched a 15-day...

BNXTF : 0.4426 (+0.52%)
BioNxt Enters the Final Stretch Before Human Trials for Next-Generation MS Drug PressReach - Wed Oct 22, 12:25PM CDT

BioNxt Solutions Inc. (CSE:BNXT) (OTCQB:BNXTF) (FSE:BXT), a bioscience company developing next-generation drug delivery technologies, has launched a 15-day dosing optimization study for its lead product...

BNXT.CN : 0.6300 (+5.00%)
BNXTF : 0.4426 (+0.52%)
BioNxt Launches 15-day Sublingual Cladribine Dosing Optimization Study in Preparation for Human Bioequivalence Study PressReach - Tue Oct 21, 9:23AM CDT

VANCOUVER, BC / October 21, 2025 / BioNxt Solutions Inc. (“BioNxt” or the “Company”) (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in next-generation drug delivery technologies,...

BNXT.CN : 0.6300 (+5.00%)
BNXTF : 0.4426 (+0.52%)
BioNxt Secures Fast-Track Patent Filing for MS Treatment Tipranks - Sat Oct 11, 2:10PM CDT

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. BioNxt Solutions...

BNXTF : 0.4426 (+0.52%)
BioNxt Solutions Completes Debt Settlement to Strengthen Financial Position Tipranks - Sat Oct 11, 2:10PM CDT

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An announcement...

BNXTF : 0.4426 (+0.52%)
BioNxt Solutions Strengthens Market Position with Strategic Advisor and Investor Relations Team Tipranks - Sat Oct 11, 2:10PM CDT

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. BioNxt Solutions...

BNXTF : 0.4426 (+0.52%)
BioNxt Advances Targeted Chemotherapy Delivery Platform Tipranks - Sat Oct 11, 2:10PM CDT

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. BioNxt Solutions...

BNXTF : 0.4426 (+0.52%)
BioNxt Advances Semaglutide Oral Film with Successful Trials Tipranks - Sat Oct 11, 2:10PM CDT

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest...

BNXTF : 0.4426 (+0.52%)

Barchart Exclusives

The 2 Riskiest Stocks Investors Are Betting On With Over 300% Upside Barchart - Sat Dec 20, 11:00AM CST
These biotech bets are only for investors who can stomach volatility. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot